Announced
Completed
AIMMUNE THERAPEUTICS INC / NESTLE / Acquisition / Public
Synopsis
Equity investment in Aimmune Therapeutics, a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ImmunoTherapy), by Nestlé Health Science.
Principals
Show Details & Financials
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.